482 related articles for article (PubMed ID: 17428293)
21. Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice.
Li XM; Metzger G; Filipski E; Boughattas N; Lemaigre G; Hecquet B; Filipski J; Levi F
Toxicol Appl Pharmacol; 1997 Apr; 143(2):281-90. PubMed ID: 9144445
[TBL] [Abstract][Full Text] [Related]
22. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
[TBL] [Abstract][Full Text] [Related]
23. Delayed repair: the role of glutathione in a rat incisional wound model.
Adamson B; Schwarz D; Klugston P; Gilmont R; Perry L; Fisher J; Lindblad W; Rees R
J Surg Res; 1996 May; 62(2):159-64. PubMed ID: 8632633
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
Neuwelt EA; Pagel MA; Hasler BP; Deloughery TG; Muldoon LL
Cancer Res; 2001 Nov; 61(21):7868-74. PubMed ID: 11691805
[TBL] [Abstract][Full Text] [Related]
25. The liver-selective nitric oxide donor O2-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (V-PYRRO/NO) protects HepG2 cells against cytochrome P450 2E1-dependent toxicity.
Gong P; Cederbaum AI; Nieto N
Mol Pharmacol; 2004 Jan; 65(1):130-8. PubMed ID: 14722244
[TBL] [Abstract][Full Text] [Related]
26. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
Rosenberg MC; Colvin OM; Griffith OW; Bigner SH; Elion GB; Horton JK; Lilley E; Bigner DD; Friedman HS
Cancer Res; 1989 Dec; 49(24 Pt 1):6917-22. PubMed ID: 2582434
[TBL] [Abstract][Full Text] [Related]
27. Effect of glutathione depletion on exocyclic adduct levels in the liver DNA of F344 rats.
Nath RG; Ocando JE; Richie JP; Chung FL
Chem Res Toxicol; 1997 Nov; 10(11):1250-3. PubMed ID: 9403178
[TBL] [Abstract][Full Text] [Related]
28. Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis.
Pan HN; Sun R; Jaruga B; Hong F; Kim WH; Gao B
Alcohol Clin Exp Res; 2006 Sep; 30(9):1615-23. PubMed ID: 16930225
[TBL] [Abstract][Full Text] [Related]
29. Lysosomal leakage and lack of adaptation of hepatoprotective enzyme contribute to enhanced susceptibility to ethanol-induced liver injury in female rats.
Donohue TM; Curry-McCoy TV; Nanji AA; Kharbanda KK; Osna NA; Radio SJ; Todero SL; White RL; Casey CA
Alcohol Clin Exp Res; 2007 Nov; 31(11):1944-52. PubMed ID: 17850215
[TBL] [Abstract][Full Text] [Related]
30. Changes in rat liver gene expression induced by thioacetamide: protective role of S-adenosyl-L-methionine by a glutathione-dependent mechanism.
Mesa ML; Carrizosa R; MartÃnez-Honduvilla C; Benito M; Fabregat I
Hepatology; 1996 Mar; 23(3):600-6. PubMed ID: 8617442
[TBL] [Abstract][Full Text] [Related]
31. Lack of enhanced myelotoxicity with buthionine sulfoximine and sulfhydryl-dependent anticancer agents in mice.
Soble MJ; Dorr RT
Res Commun Chem Pathol Pharmacol; 1987 Feb; 55(2):161-80. PubMed ID: 3823607
[TBL] [Abstract][Full Text] [Related]
32. Chronic ethanol consumption alters the glutathione/glutathione peroxidase-1 system and protein oxidation status in rat liver.
Bailey SM; Patel VB; Young TA; Asayama K; Cunningham CC
Alcohol Clin Exp Res; 2001 May; 25(5):726-33. PubMed ID: 11371722
[TBL] [Abstract][Full Text] [Related]
33. Glutathione depletion in rested and exercised mice: biochemical consequence and adaptation.
Leeuwenburgh C; Ji LL
Arch Biochem Biophys; 1995 Feb; 316(2):941-9. PubMed ID: 7864653
[TBL] [Abstract][Full Text] [Related]
34. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
35. Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in mice.
Soble MJ; Dorr RT
Anticancer Res; 1988; 8(1):17-22. PubMed ID: 3358633
[TBL] [Abstract][Full Text] [Related]
36. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
Sun JD; Ragsdale SS; Benson JM; Henderson RF
Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
Wu HY; Kang YJ
J Pharmacol Exp Ther; 1998 Nov; 287(2):515-20. PubMed ID: 9808675
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma.
Palomares T; Bilbao P; del Olmo M; Castro B; Calle Y; Alonso-Varona A
Melanoma Res; 1999 Jun; 9(3):233-42. PubMed ID: 10465578
[TBL] [Abstract][Full Text] [Related]
39. Induction of rat UDP-glucuronosyltransferase and glutathione S-transferase activities by L-buthionine-S,R-sulfoximine without induction of cytochrome P-450.
Manning BW; Franklin MR
Toxicology; 1990 Dec; 65(1-2):149-59. PubMed ID: 2125759
[TBL] [Abstract][Full Text] [Related]
40. Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication.
Kera Y; Ohbora Y; Komura S
Alcohol Alcohol; 1989; 24(6):519-24. PubMed ID: 2576368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
